GC
RMTI icon

Guggenheim Capital’s Rockwell Medical RMTI Stock Holding History

Guggenheim Capital’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-206
Closed -$232K – 2984
2015
Q4 		$232K Buy
206
+110
+115% +$128K ﹤0.01% 2723
2015
Q3 		$82K Sell
96
-5
-5% -$7.25K ﹤0.01% 2819
2015
Q2 		$178K Sell
101
-5
-5% -$6.36K ﹤0.01% 2841
2015
Q1 		$127K Buy
+106
New +$124K ﹤0.01% 2841
2014
Q3 		– Sell
-172
Closed -$227K – 3098
2014
Q2 		$227K Sell
172
-18
-9% -$21.7K ﹤0.01% 2860
2014
Q1 		$265K Buy
190
+31
+19% +$40.3K ﹤0.01% 2786
2013
Q4 		$184K Buy
159
+2
+1% +$2.76K ﹤0.01% 2866
2013
Q3 		$196K Buy
157
+46
+41% +$31.2K ﹤0.01% 2737
2013
Q2 		$44K Buy
+111
New +$47.1K ﹤0.01% 2918

Other funds holding RMTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Guggenheim Capital's RMTI Position: Q1 2016 in Review

Guggenheim Capital sold out of Rockwell Medical (RMTI) in Q1 2016, closing a stake of 206 shares — an estimated $232K sold.

Guggenheim Capital first reported a position in RMTI in Q2 2013 and held it in 9 quarters. The position peaked at $265K in Q1 2014. 91 funds tracked by Wall St. Rank hold RMTI as of Q1 2016.

  • Guggenheim Capital reported no remaining Rockwell Medical position as of Q1 2016 after selling out during the quarter.
  • Guggenheim Capital sold 206 Rockwell Medical shares in Q1 2016, an estimated $232K.
  • Guggenheim Capital first reported a position in Rockwell Medical in Q2 2013 and held it in 9 quarters.
  • Guggenheim Capital's Rockwell Medical position peaked at $265K in Q1 2014.
  • 91 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2016.

Based on Guggenheim Capital's 13F filing for Q1 2016, filed 16 May 2016.